Total Payments
$4,946
2024 Payments
$1,060
Companies
29
Transactions
309
Medicare Patients
3,743
Medicare Billing
$587,168
Payment Breakdown by Category
Food & Beverage$4,928 (99.6%)
Consulting$18.44 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,928 | 308 | 99.6% |
| Consulting Fee | $18.44 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,689 | 115 | $0 (2024) |
| Celgene Corporation | $349.33 | 19 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $346.37 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $263.75 | 26 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $258.43 | 14 | $0 (2024) |
| Gilead Sciences, Inc. | $251.39 | 14 | $0 (2024) |
| PFIZER INC. | $209.33 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $199.78 | 12 | $0 (2023) |
| Daiichi Sankyo Inc. | $198.40 | 11 | $0 (2023) |
| Janssen Biotech, Inc. | $192.60 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,060 | 50 | ABBVIE INC. ($381.96) |
| 2023 | $926.93 | 47 | ABBVIE INC. ($315.52) |
| 2022 | $492.00 | 31 | ABBVIE INC. ($175.27) |
| 2021 | $346.58 | 26 | AbbVie Inc. ($189.63) |
| 2020 | $319.01 | 25 | AbbVie Inc. ($171.01) |
| 2019 | $757.76 | 57 | AbbVie, Inc. ($340.64) |
| 2018 | $661.41 | 47 | AbbVie, Inc. ($114.95) |
| 2017 | $382.72 | 26 | Braintree Laboratories, Inc. ($85.17) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.33 | General |
| Category: GI | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/19/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Rare Disease | ||||||
| 09/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Immunology | ||||||
| 07/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.09 | General |
| 07/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.36 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 714 | 858 | $606,283 | $104,922 |
| 2022 | 17 | 1,010 | 1,295 | $832,530 | $171,543 |
| 2021 | 16 | 1,051 | 1,457 | $712,242 | $172,754 |
| 2020 | 18 | 968 | 1,263 | $662,260 | $137,950 |
Total Patients
3,743
Total Services
4,873
Medicare Billing
$587,168
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 72 | 72 | $102,672 | $24,033 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 207 | $73,200 | $17,995 | 24.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 67 | 67 | $95,542 | $13,847 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $41,734 | $8,965 | 21.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 47 | 48 | $71,686 | $8,839 | 12.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 20 | 20 | $30,000 | $4,226 | 14.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 16 | 16 | $19,174 | $3,964 | 20.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 36 | 36 | $41,892 | $3,201 | 7.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $13,650 | $2,974 | 21.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $57,000 | $2,696 | 4.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 42 | $9,954 | $2,621 | 26.3% |
| 45331 | Biopsy of lower large bowel using a flexible endoscope | Office | 2023 | 11 | 11 | $9,810 | $2,388 | 24.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 52 | $9,984 | $2,320 | 23.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 58 | $8,410 | $1,945 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 29 | $6,873 | $1,930 | 28.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $5,370 | $1,329 | 24.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 27 | $3,834 | $991.94 | 25.9% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 13 | 13 | $5,498 | $657.28 | 12.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 142 | 142 | $220,728 | $53,387 | 24.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 94 | 94 | $143,744 | $18,742 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 182 | $42,674 | $16,535 | 38.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 49 | 49 | $51,413 | $13,299 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 113 | 113 | $42,918 | $13,208 | 30.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 59 | 59 | $85,831 | $9,554 | 11.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 23 | 23 | $28,690 | $8,015 | 27.9% |
About Dr. Arun Mannem, MD
Dr. Arun Mannem, MD is a Hospitalist healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1871721019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arun Mannem, MD has received a total of $4,946 in payments from pharmaceutical and medical device companies, with $1,060 received in 2024. These payments were reported across 309 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,928).
As a Medicare-enrolled provider, Mannem has provided services to 3,743 Medicare beneficiaries, totaling 4,873 services with total Medicare billing of $587,168. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Location Saint Louis, MO
- Active Since 06/25/2009
- Last Updated 08/21/2012
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1871721019
Products in Payments
- RINVOQ (Biological) $405.86
- ZEPOSIA (Drug) $349.33
- HUMIRA (Biological) $332.10
- LINZESS (Drug) $316.33
- XIFAXAN (Drug) $272.89
- Humira (Biological) $243.45
- DIFICID (Drug) $199.78
- Linzess (Drug) $189.58
- SKYRIZI (Biological) $181.75
- INJECTAFER (Drug) $176.80
- Entyvio (Biological) $143.49
- STELARA (Biological) $121.41
- DUPIXENT (Biological) $117.43
- ENTYVIO (Biological) $114.56
- XELJANZ (Drug) $106.52
- CREON (Drug) $98.86
- SUPREP (Drug) $85.17
- Mavyret (Drug) $76.43
- VELSIPITY (Drug) $73.74
- IBSRELA (Drug) $66.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Saint Louis
Ms. Marsha Schulte, Anp, ANP
Hospitalist — Payments: $22,644
Hospitalist $22,644
Rowena Santos, Md, MD
Hospitalist — Payments: $16,037
Hospitalist $16,037
David Yu, M.d, M.D
Hospitalist — Payments: $10,632
Hospitalist $10,632
Dr. Jeffrey Parker, Md, MD
Hospitalist — Payments: $7,947
Hospitalist $7,947
Dr. Patrick White, Md, MD
Hospitalist — Payments: $6,531
Hospitalist $6,531
Woo Moon, Do, DO
Hospitalist — Payments: $3,550
Hospitalist $3,550